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Abstract
 
Activation-induced cytosine deaminase preferentially deaminates C in DNA on the nontran-
scribed strand in vitro, which theoretically should produce a large increase in mutations of C
during hypermutation of immunoglobulin genes. However, a bias for C mutations has not
been observed among the mutations in variable genes. Therefore, we examined mutations in
the 
 
  
 
and 
 
  
 
switch regions, which can form stable secondary structures, to look for C mutations.
To further simplify the pattern, mutations were studied in the absence of DNA polymerase
(pol) 
 
 
 
, which may produce substitutions of nucleotides downstream of C. DNA from lym-
phocytes of patients with xeroderma pigmentosum variant (XP-V) disease, whose polymerase
 
  
 
is defective, had the same frequency of switching to all four 
 
  
 
isotypes and hypermutation in
 
 
 
-
 
  
 
switch sites (0.5% mutations per basepair) as control subjects. There were fewer mutations
of A and T bases in the XP-V clones, similar to variable gene mutations from these patients,
which confirms that polymerase 
 
  
 
produces substitutions opposite A and T. Most importantly,
the absence of polymerase 
 
  
 
revealed an increase in C mutations on the nontranscribed strand.
This data shows for the first time that C is preferentially mutated in vivo and pol 
 
  
 
generates
hypermutation in the 
 
  
 
and 
 
  
 
switch regions.
Key words: somatic hypermutation • activation-induced cytosine deaminase • 
xeroderma pigmentosum variant • gap-ﬁlling repair • translesion replication
 
Introduction
 
Immunoglobulin diversity is achieved in mammals at three
molecular levels: joining of variable (V), diversity, and joining
gene segments; hypermutation of rearranged V genes; and
switching of heavy chain constant (C) genes. The latter
two processes depend on the activation-induced cytosine
deaminase (AID) protein. Mice and humans without AID
have neither V gene mutations nor C gene switching (1, 2).
This implies that the two processes, which involve different
mechanisms that generate point mutations and double
strand breaks, share common enzymes. Biochemical and
genetic experiments indicate that AID functions to deaminate
cytosine in DNA to uracil (3–10). Using gene-deficient
mice and humans, several other proteins have been shown
to alter the pattern of mutation and switching. First, uracil
DNA glycosylase is required to remove uracil lesions in
DNA. Mice and humans deficient for the enzyme have
altered V gene mutations and deficient heavy chain switch-
ing (5, 11). Second, the mismatch repair proteins Msh2,
Msh6, Pms2, and Mlh1, participate in an unknown way
to change the pattern of V gene mutations and C gene
switching in gene-deficient mice (12–18). Third, DNA
polymerase (pol) 
 
  
 
plays a role in generating mutations in
V genes at A and T nucleotides. Humans with xeroderma
pigmentosum variant (XP-V) disease whose pol 
 
  
 
is defective
have fewer A:T substitutions (19).
Mutations have also been detected in introns containing
the recombination sites of switched C genes (20). Mutations
are even found in the 
 
  
 
switch region before switching in
murine B cells stimulated in culture, and they are dependent
on AID expression (21, 22). Although mutations in V
genes have the potential to change the coding sequence to
produce high affinity antibodies, mutations in the switch
regions likely reflect the footprints of AID deamination
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that precede DNA strand breaks. Actual recombination re-
quires additional factors because defects in the carboxy-ter-
minal region of the AID protein do not affect hypermuta-
tion but eliminate switching (23, 24).
In vitro, AID preferentially deaminates C on single
stranded DNA or on the nontranscribed strand during tran-
scription (6–10, 25). This leads to the conundrum that
there should be a large increase in mutations of C com-
pared with those of G, A, and T, as recorded from the non-
transcribed strand. However, in vivo, mutations of all four
nucleotides in V genes are approximately equal in fre-
quency (26), suggesting that other proteins, e.g., mismatch
repair proteins and pols, generate mutations downstream of
deaminated cytosines. In this study, we looked for a C bias
in mutations from switch regions, which can form stable
secondary structures that expose single strands. To further
simplify the pattern, we removed pol 
 
  
 
and analyzed muta-
tions in the 
 
 
 
-
 
  
 
switch joins from three XP-V patients. We
show that XP-V patients have normal switching, but as in
V genes, there were fewer mutations of A and T nucle-
otides. Furthermore, the absence of pol 
 
  
 
revealed prefer-
ential targeting of C bases for mutation.
 
Materials and Methods
 
DNA Preparation from Peripheral Blood Lymphocytes.
 
Periph-
eral blood was obtained from patients XP11BR, XP31BE, and
XP7BR as previously described (19), and control donors as re-
ported (27). DNA was extracted with phenol-chloroform and
suspended in Tris-EDTA buffer.
 
Libraries of 
 
 
 
-
 
  
 
Switch Regions.
 
Hybrid switch sites containing
 
  
 
and 
 
  
 
switch (S) regions were amplified by PCR using primers
flanking the repetitive core regions of S
 
  
 
and S
 
 
 
. The S
 
  
 
primers
were specific for a conserved region downstream of all S
 
  
 
sequences,
and thus would detect 
 
 
 
3, 
 
 
 
1, 
 
 
 
2, and 
 
 
 
4 switches (28). The follow-
ing sets of nested primers were used: first set, S
 
  
 
forward (nucle-
otides 91–110 from GenBank/EMBL/DDBJ under accession no.
54713), 5
 
 
 
CAAGCAGGTCTGGTGGGCTG; S
 
  
 
reverse (nucle-
otides 2911–2933 from GenBank/EMBL/DDBJ under accession
no. U39737), 5
 
 
 
CTTGCCAACTGCTCAGTGGGATG; second
set, S
 
  
 
forward (nucleotides 118–141 from GenBank/EMBL/DDBJ
under accession no. X54713) with EcoRI addition in italics,
5
 
 
 
GCCGGAATTC
 
CTGGCCATGACAACTCCATCCAGC; S
 
 
 
reverse (nucleotides 2861–2882 of U39737) with BamHI addition in
italics, 5
 
 
 
GCGGGATCC
 
GGCTGCACTGCACTTTCACCAG.
15 ng genomic DNA was amplified with Pfu polymerase in 50 
 
 
 
l
volume using the first set of primers for 30 cycles of 95
 
 
 
C for 45 s,
55
 
 
 
C for 1 min, and 72
 
 
 
C for 2 min, followed by a final incubation
at 72
 
 
 
C for 10 min. 5 
 
 
 
l of this reaction was then reamplified in 50
 
 
 
l with the second set of primers for an additional 30 cycles. The
PCR products were cloned into EcoRI and BamHI-digested pBlue-
script and plasmids containing unique inserts were sequenced.
 
Determination of PCR Error.
 
To assess PCR error, unrear-
ranged S
 
 
 
1 regions from all six subjects were sequenced from the
same DNA using the same procedures as described above. The
following sets of primers were used to generate a 1.37-kb product:
first set, S
 
  
 
forward (nucleotides 1430–1449 from GenBank/
EMBL/DDBJ under accession no. U39737), 5
 
 
 
AAGCAGAAA-
GATCAGGGGTC; S
 
  
 
reverse as above; second set, S
 
  
 
forward
(nucleotides 1505–1523 from GenBank/EMBL/DDBJ under ac-
cession no. U39737) with EcoRI addition in italics, 5
 
 
 
CGGAA-
TTC
 
CTCAGCCTCAGGGAGCCAGG; S
 
  
 
reverse with BamH1
as above. 20 ng genomic DNA was amplified with Platinum Pfx
polymerase and PCRx enhancer (Invitrogen) in 50 
 
 
 
l volume us-
ing the first set of primers for 30 cycles of 95
 
 
 
C for 30 s, 55
 
 
 
C for
1 min, and 68
 
 
 
C for 2 min, followed by a final incubation at 68
 
 
 
C
for 10 min. Nested PCR was performed with 5 
 
 
 
l of the first re-
action and the second set of primers with an annealing and exten-
sion step of 68
 
 
 
C for 2 min for another 30 cycles. Products were
digested, cloned, and sequenced.
 
Online Supplemental Material.
 
Figs. S1–S6 present the data
from three XP-V and three control groups of clones. They con-
tain a summary of clone length, isotypes, and microhomology,
sequences of the 
 
  
 
and 
 
  
 
switch regions, and examples of micro-
homology at the 
 
 
 
-
 
  
 
junctions. Figs. S1–S6 are available at http://
www.jem.org/cgi/content/full/jem.20032022/DC1.
 
Results
 
XP-V Patients Have Normal Class Switch Recombination.
 
To analyze C
 
  
 
to C
 
  
 
switching and identify mutations in
the switch regions from DNA pol 
 
 
 
–deficient humans, pe-
ripheral blood was obtained from three XP-V patients. The
DNA repair defects in these patients have been described,
and the mutations in their 
 
POLH
 
 genes were expected to
inactivate pol 
 
  
 
(19). Recombined switch sites associated
with S
 
  
 
and S
 
  
 
regions were sequenced from cloned PCR
products derived from the DNA of the XP-V patients and
three control individuals. To avoid nonspecific priming in
the repetitive sequences, DNA was amplified with nested
primers. Inserts ranged in size from 100 to 600 bp. The 
 
 
 
isotypes and mutations in the switching sites were identi-
fied by comparing the recombined S
 
 
 
-S
 
  
 
regions to the
germline S
 
  
 
sequence and to all four S
 
  
 
sequences (28). As
shown in Table I, usage of the 
 
  
 
isotypes for XP-V and
control clones was similar, with over half of the clones
containing 
 
  
 
to 
 
 
 
1 switches. Breakpoints in the 
 
  
 
and 
 
 
 
regions occurred randomly, and there was no difference
between the two groups in the lengths of microhomology
at the joining sites. Approximately half of the clones had
insertions or no microhomology at the 
 
 
 
-
 
  
 
joins, and half
had homology of one to five nucleotides. Summaries of all
 
Table I.
 
Immunoglobulin G Switch Region Isotypes in XP-V and 
Control Clones
 
Number of clones
Subject Total
 
  
 
to 
 
 
 
3
 
  
 
to 
 
 
 
1
 
  
 
to 
 
 
 
2
 
  
 
to 
 
 
 
4
 
  
 
to ?
 
a
 
XP11BR 23 4 15 1 2 1
XP31BE 23 4 14 4 0 1
XP7BR 25 3 14 6 1 1
Control 1 31 4 14 3 2 8
Control 2 20 3 14 0 2 1
Control 3 16 0 13 0 3 0
 
a
 
Nucleotide sequence after the 
 
  
 
break was not identified. 
Zeng et al.
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the clones, sequences, and examples of microhomology are
included in Figs. S1–S6, available at http://www.jem.org/
cgi/content/full/jem.20032022/DC1.
 
Mutations Are Located throughout 
 
  
 
and 
 
  
 
Switch Regions.
 
The sequenced S
 
  
 
region was nonpolymorphic among the
six subjects, so that mutations were readily identified. The
S
 
  
 
regions were polymorphic, and germline S
 
 
 
1 sequences
were identified for each human. To avoid errors in assign-
ing mutations for the other isotypes, only unique mutations
were counted. Over two thirds of the clones from both
study groups had mutations. As seen in Table II, the overall
frequency of mutation was similar between XP-V and con-
trol clones, with an average of 0.5% mutations per bp. This
was significantly higher than the mutation frequency in un-
rearranged S
 
 
 
1 regions (P    10 4, Fisher’s exact test),
which is reported to be similar to the frequency of PCR
error (29). As in V genes, the majority of mutations were
base substitutions, although the frequency of deletions was
much higher in the switch region ( 13% of mutations)
compared with that in introns flanking rearranged V genes
(1%). Approximately 2% of the mutations within the switch
sequences were insertions and 16% of the clones had inser-
tions at the junction site. The distance and frequency of
mutations from the recombination sites of S  and S  are
shown in Fig. 1. Mutations were scattered throughout the
switch regions and occurred as far as 200 bp from the join-
ing site. Preferential clustering of mutations around the
break points was not observed.
Mutations May Occur Before, During, and After Switching.
Related clones were identified in all the libraries and likely
derive from clonal progeny that have undergone sequential
mutations. Approximately one third of the clones were re-
lated as defined by the same length of   and/or   sequences
and the same site of joining. Based on the pattern of shared
and unique mutations in related clones, it is possible to esti-
mate when the mutations occurred. As shown in Fig. 2 A,
mutations could happen before switching in the unrecom-
bined   region, as demonstrated by two clones with identi-
cal substitutions that were joined to different S  sequences.
Mutations in the S  region before switching have been
well documented in the literature (21, 22, 29), indicating
that they precede recombination. In Fig. 2 B, mutations
could occur during switching as shown by insertions of
nontemplated nucleotides at the site of joining. In Fig. 2 C,
mutations probably occurred after switching in three sets of
clones that had identical   and   joins and shared muta-
tions, as well as unique mutations.
Pol   Is an A-T Mutator in the  -  Switch Regions. The
types of base substitutions were examined to see if there
was a difference between XP-V and control clones. All
Table II. Types of Mutation in  -  Switch Regions
Numbera of
Subject Frequency (% mutation/bp) Nucleotides sequenced Substitutions Deletions Insertions
XP11BR 0.59 5549 26 6 1
XP31BE 0.35 5681 20 0 0
XP7BR 0.51 5840 28 2 0
Control 1 0.75 6028 38 6 1
Control 2 0.49 5128 19 6 0
Control 3 0.56 4259 20 3 1
PCR errorb 0.08 7248 5 1 0
aDoes not include mutations or insertions at the  -  junctions.
bMutations in recombined switch regions differed significantly from PCR error, P   10 4.
Figure 1. Mutations are distributed throughout the  -  switch regions
at a high frequency. The top schematic drawing shows the recombined  
(solid) and   (striped) switch regions with an arrow indicating the breakpoint.
On the abscissa, mutations are plotted on either side of the breakpoint for
XP-V and control clones. On the ordinate, the frequency of mutation per
10 nucleotide increments was calculated as the number of mutations in
the increment, divided by 10, divided by the number of times the increment
was sequenced, and multiplied by 100.Bias for C Mutations in Switch Regions 920
mutations were recorded from the nontranscribed strand.
There was a decrease in mutations of A and T, and a corre-
sponding increase in mutations of G and C in the XP-V
clones (Fig. 3 A). All three XP-V patients had clones with
decreased A:T mutations (Fig. 3 B), indicating that pol   is
involved in generating mutations in the switch regions.
Comparing mutations of A or T versus mutations of G or
C, there is a highly significant difference among the XP-V
and control clones (P   0.0035, using a Monte Carlo anal-
ysis; reference 30). In addition to transitions of G and C,
there was a strong bias for G to C and C to G transversions
in both groups of clones. For example, of the mutations of
G and C, 58% were G:C to A:T transitions, 8% were G:C
to T:A transversions, and 34% were G:C to C:G transver-
sions. There was no difference in the types of mutations lo-
cated within 15 bp of the switch junction and those located
farther away.
C on the Nontranscribed Strand Is Targeted for Mutation in
XP-V Clones. Because the S   sequence was nonpoly-
morphic, we analyzed mutations there in more detail.
Some 130 nucleotides of the S  region located upstream of
the repetitive core sequences are shown in Fig. 4. The lo-
cation of mutations reveals a hotspot at C in position 39
(position 180 in GenBank/EMBL/DDBJ under accession
no. X54713) in both XP-V and control clones. The posi-
tion is in a WRC motif (31), although it is unclear why this
particular position is favored over the other WRC se-
quences in Fig. 4. When all the substitutions in the 350-
nucleotide S  region were tabulated (Fig. 5 A), it became
apparent that C was preferentially mutated compared with
G in the XP-V clones (Fig. 5 B). Some 70% of the 52 mu-
tations are at C nucleotides in XP-V clones compared with
47% of 50 mutations in the control clones (P   0.05). Tar-
geting of C bases is also observed when the S  substitutions
are included (Fig. 3 A). 58 and 45% are at C in XP-V and
control clones, respectively, compared with 29 and 28% at
G, respectively. Half of the C mutations in XP-V clones
were C to T transitions and half were C to G transversions.
Discussion
Switch Regions Are Hotspots for Hypermutation. The im-
portance of the switch region as a hypermutation target has
only recently been recognized. Mutations have been re-
ported in S  regions from mice and humans (21, 22, 32),
Figure 2. Mutations can occur sequentially in clonal progeny before
and after switching. Clonal daughters were identified by identical break-
points and unique mutations are depicted by arrows. (A) Before switching
in the   region, two clones (control 1, 2–21 and 93) with identical mutations
in   were joined to  3 and  1. (B) During switching, two unique clones
(control 1: 2–24 and 4-B4) had nucleotide insertions at the site of joining.
(C) After switching, three examples are shown. In the   region, two
clones (control 2: 11A9 and 11G9) with identical  3 junctions had different
mutations in  . Also in the   region, three clones (XP7BR: 12D12, 65,
and 67) with identical  1 regions had different mutations in  . In the  
and   regions, two clones (XP11BR: 5A1 and 5A2) with the same junction
had different mutations in   and  . Sequences of these clones are shown
in Figs. S1, S3, and S4.
Figure 3. Pol   mutates A and T nucleotides in  -  switch regions.
(A) Substitutions in clones from three XP-V and three control subjects
show differences in spectra. Data have been corrected for nucleotide
composition of the S , S 1, S 2, S 3, and S 4 regions that were sequenced.
(B) Substitutions from each individual are grouped as A:T and G:C pairs.Zeng et al. 921
and as we describe here, extensive mutations are found in
the S  regions as well. The overall frequency of mutation
in these human clones is 0.5% mutations per bp, which is
identical to the frequency of mutation seen in intron re-
gions adjacent to rearranged VH genes from humans (un-
published data). Therefore, the question of how AID is tar-
geted must take into account the sequences of two very
different regions of DNA. Targeting to the V region might
be initiated by association with the transcription complex
near the V gene promoter (33). Similarly, targeting to the
distal switch sites may occur by association with the tran-
scription complexes that form upstream of unrearranged
switch regions (34). The location of mutations in the 130-
nucleotide S   sequence from both XP-V and control
clones (Fig. 4) indicates a hotspot at 39C, which is also ob-
served in another report (32) and may represent a major
entry point for AID. This hotspot, located at the 5  begin-
ning of the S  pentamer core motifs, is not in a palindro-
mic stem-loop structure, but might be favored in the for-
mation of other secondary structures.
Successive mutations in clonal progeny have been docu-
mented in V gene clones and indicate that mutations are
generated over several rounds of division of B cells in ger-
minal centers. Here we show that mutations also occur se-
quentially in the switch regions. As demonstrated in Fig. 2,
related clones have the same site of joining in S  and S ,
and contain both shared and unique mutations. It appears
that mutations can occur before, during, and after joining
in S  and S . Mutations before switching have been re-
ported by others (21, 22, 29) and suggest that switch re-
gions undergo multiple deaminations, and repair of the le-
sions produces mutations and occasional deletions caused
by strand breaks. Internal deletions in switch regions have
been previously noted (35–37). Among the mutations in
this study, 13% were internal deletions in S  and S . Pre-
sumably breaks of this type could also trigger recombina-
tion between different switch regions. Mutations during
switching (20, 38) are clearly identified at the junctions be-
tween S  and S , where insertions are commonly found.
Even after recombination, the hybrid S -S   sequences
continue to sustain more mutations, more breaks, and
likely sequential switching (28, 39) to downstream C
genes. Successive mutations would explain why the muta-
tional pattern is spread out over 200 bp from the junction
site (Fig. 1; reference 32) in these human clones. In contrast
to short-term cultures of murine lymphocytes where the
mutational pattern is more clustered around the junction
site (40), human peripheral B cells are long-lived and could
accumulate mutations long after switching.
Absence of DNA Pol    Reveals Increased C Mutations.
DNA pol   is a low fidelity polymerase that preferentially
generates mutations opposite A and T nucleotides in vitro
(41, 42). Humans with XP-V disease are deficient in pol  ,
and their V genes have fewer mutations of A and T, which
is consistent with pol   being an A-T mutator in hypermu-
tation (19). To determine if pol   is also involved in gener-
ating mutations in switch regions, we examined the spectra
of mutations in clones from three XP-V patients and three
control subjects. Both groups had the same frequency of
mutation and similar   isotypes, but the XP-V clones had
Figure 4. Location of substitutions in the   switch region. The 130-base region shown is from HSIGHMUS X54713 (nucleotides 142–271). Mutations
from XP-V and control clones are shown above and below the germline sequence, respectively. Every 10th base is underlined.
Figure 5. C bases in the   switch region are preferentially mutated in pol
 –deficient clones. (A) Substitutions were corrected for nucleotide compo-
sition of each clone. (B) Total mutations of each nucleotide are shown for
XP-V and control clones, with standard errors for individual variation.Bias for C Mutations in Switch Regions 922
fewer mutations of A and T bases, suggesting that pol   syn-
thesizes mutations in both the V and switch regions. The
mutation frequency is not decreased in the XP-V clones,
perhaps because AID repeatedly deaminates C bases and
produces more C:G substitutions in the absence of pol  .
Biochemical evidence indicates that AID preferentially
deaminates C on the nontranscribed strand, which would
be single stranded during transcription (7, 8, 10). However,
the mutational spectra in V gene introns show an equal fre-
quency of C and G mutations on the nontranscribed strand
(5, 43). This suggests that the separation of DNA in V genes
during transcription might be too transient to favor deami-
nation on one strand versus the other, or that pols insert
mutations downstream of the initial C lesion. In contrast,
DNA in switch regions is rich in G and C nucleotides and
has been suggested to form stable secondary structures in-
cluding R loops (44, 45), G-quartets (46), and stem loops
(47). These structures might be induced by transcription
(48) and expose C on the nontranscribed strand for deami-
nation for a length of time. In support of this model, we ob-
served an increase in mutations of C on the nontranscribed
strand in human S  and S  regions. A slight increase was
seen in the mutations from control clones, and this effect
was dramatically augmented in XP-V clones where some
70% of mutations were at C bases in S  (Fig. 5).
The three major categories of hypermutation in the
switch regions from control subjects are substitutions of A
and T, transversions of C:G to G:C, and transitions of C:G
to T:A. We propose a model to explain how these muta-
tions are generated (Fig. 6). Substitutions of A and T could
occur during gap-filling repair of the abasic site on the
nontranscribed strand by pol  , which synthesizes DNA
downstream of the initial C lesion to generate mutations
opposite all four nucleotides. Pol   could synthesize a gap
produced by exonuclease 1 (49) and/or perform strand dis-
placement (43). In the absence of pol  , mutations would
occur primarily at sites of deaminated cytosines, which is
why C is targeted in the XP-V clones. In the second cate-
gory, transversions of C:G to G:C could occur during rep-
lication past the abasic site by a translesion polymerase. Half
of the mutations of C in XP-V clones were C to G trans-
versions, and a high frequency of transversions was also
found in the control clones (Fig. 5; reference 32). C to G
transversions could be specifically generated by Rev1,
which is a deoxycytidyl transferase that inserts C opposite
an abasic site (50, 51). The chicken DT40 B cell line makes
a preponderance of C:G to G:C transversions in immuno-
globulin V genes (52), and deletion of Rev1 eliminates
these mutations (53), indicating that this polymerase is in-
volved in chicken hypermutation. Our data support the
notion that Rev1 participates in human switch mutations as
well. Rev1 associates with several polymerases, including
pol  , pol  , and pol   (50, 54), and might be recruited to
the mutation site in a multiprotein complex. The third cat-
egory of mutations is C:G to T:A transitions. Transitions
could arise during error-prone repair by preferential inser-
tion of T opposite G by pol  , or during replication past
uracil by any polymerase.
In addition to pol  , the mismatch repair proteins Msh2
and Msh6 participate in generating mutations of A and T
bases in V genes. It remains to be determined how the low
fidelity pols and mismatch repair proteins are recruited to
deaminated cytosines in the immunoglobulin locus, and
how pol   and Msh2/Msh6 produce A:T mutations.
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Note added in proof. Two recent papers have also observed a prefer-
ence for C mutations on the non-transcribed strand in switch re-
gions: Cook et al. (55) and Faili et al. (56).
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